Evidence map›Paper›PMID 29696832›Full record

Trial reportPhysiological reports2018

Progesterone administration does not acutely alter LH pulse secretion in the mid-follicular phase in women.

Su Hee Kim, Christine M Burt Solorzano, Christopher R McCartney

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Physiological reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Su Hee KimDivision of Endocrinology and Metabolism, Department of Medicine, University of Virginia School of Medicine, Charlottesville, Virginia.
Christine M Burt SolorzanoCenter for Research in Reproduction, University of Virginia School of Medicine, Charlottesville, Virginia.
Christopher R McCartneyDivision of Endocrinology and Metabolism, Department of Medicine, University of Virginia School of Medicine, Charlottesville, Virginia.
University of Virginia · US

Funding

Testosterone-GnRH Frequency and the Evolution of PCOS in AdolescenceP50HD028934 · NICHD · UNIVERSITY OF VIRGINIA · PI HAISENLEDER, DANIEL J. · 2014 to 2018
$8.6M
CRR LIGAND ASSAY AND ANALYSIS CORER24HD102061 · NICHD · UNIVERSITY OF VIRGINIA · PI HAISENLEDER, DANIEL J. · 2019 to 2023
$2.2M
Pubertal hyperandrogenemia, modification of day-night GnRH secretion, and PCOSR01HD058671 · NICHD · UNIVERSITY OF VIRGINIA · PI MCCARTNEY, CHRISTOPHER ROLLAND · 2008 to 2012
$1.2M
Excess androgen production in overweight pubertal girls--precursor to PCOSK23HD070854 · NICHD · UNIVERSITY OF VIRGINIA · PI BURT SOLORZANO, CHRISTINE MICHELE · 2012 to 2016
$649k
Role of hyperandrogenemia in abnormal pubertal gonadotropin-releasing hormone (GnRH) secretion and development of PCOSF32HD088047 · NICHD · UNIVERSITY OF VIRGINIA · PI KIM, SU H. · 2016 to 2018
$141k
NICHD NIH HHS F32 HD088047NICHD NIH HHS K23 HD070854NICHD NIH HHS P50 HD028934NICHD NIH HHS R01 HD058671NICHD NIH HHS R24 HD102061
6 · The paper itself

Abstract

It remains unclear how rapidly progesterone suppresses luteinizing hormone (LH) pulse frequency in women. Previous studies suggested that progesterone markedly increases LH pulse amplitude but does not slow LH pulse frequency within 10 h in estradiol-pretreated women studied during the late follicular phase. However, this experimental paradigm may be a model of preovulatory physiology, and progesterone may have different effects at other times of the cycle. We studied regularly cycling, nonobese women without hyperandrogenism to assess the acute effect of progesterone during the midfollicular phase and in the absence of estradiol pretreatment. The study involved two admissions in separate cycles (cycle days 5-9). For each admission, either oral micronized progesterone (100 mg) or placebo was administered at 0900 h in a randomized, double-blind fashion. Frequent blood sampling was performed between 0900 and 1900 h to define 10-h LH pulsatility. Treatment crossover (placebo exchanged for progesterone and vice versa) occurred in a subsequent cycle. After an interim futility analysis, the study was halted after 7 women completed study. Mean progesterone concentrations after placebo and progesterone administration were 0.5 ± 0.1 (mean ± SD) and 6.7 ± 1.6 ng/mL, respectively. Compared to placebo, progesterone was not associated with a significant difference in 10-h LH pulse frequency (0.79 ± 0.35 vs. 0.77 ± 0.28 pulses/h, P = 1.0) or amplitude (3.6 ± 2.8 vs. 4.3 ± 2.8 IU/L, P = 0.30). This study suggests that LH pulse frequency is not rapidly influenced by progesterone administration during the midfollicular phase.

Indexed as

AdolescentCross-Over StudiesDouble-Blind MethodEstradiolFemaleFollicle Stimulating HormoneFollicular PhaseGonadotropin-Releasing HormoneHumansLuteinizing HormoneProgesteroneYoung AdultEstradiolFollicle Stimulating HormoneGonadotropin-Releasing HormoneLuteinizing HormoneProgesteroneGonadotropin-releasing hormoneluteinizing hormonenegative feedbackprogesterone

Identifiers

PMID29696832
PMCPMC5917047
OpenAlexW2801281639

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.